MedTrace Logo

Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis

NCT03814343 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2021-09-28

No results posted yet for this study

Summary

The randomized control trial study aimed to evaluate effectiveness and safety of amphotericin B in 30% DMSO solution comparing with 30% DMSO solution in NDMs onychomycosis treatment.

Conditions

Interventions

DRUG

amphotericin B in 30% DMSO

amphotericin B in 30% DMSO was given to patients in active comparators group for continuous 12 weeks.

DRUG

30% DMSO

30% DMSO was given to patients in placebo comparators group for continuous 12 weeks.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Sumanas Bunyaratavej, MD · Mahidol University

  • Charussri Leeyaphan, MD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-11-15
Completion
2020-11-30

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03814343 on ClinicalTrials.gov